bs-0094R-Cy5 [Conjugated Primary Antibody]
AACT Alpha1 Polyclonal Antibody, Cy5 Conjugated
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: AACT Alpha1

Immunogen Range: 121-320/423


Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 12

Swiss Prot: P01011

Source: KLH conjugated synthetic peptide derived from human AACT-Alpha1

Purification: Purified by Protein A.

Storage Buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Background:

Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2.

Conjugation: Cy5

Excitation/ Emission: 625,650nm/670nm

Size: 100ul

Concentration: 1ug/ul

Applications: WB(1:300-5000)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)

Predicted Molecular Weight: 45


Cross Reactive Species: Mouse
Rat

Predicted Cross Reactive Species: Human

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Wang, Robert YL, et al. "Proteome Demonstration of Alpha-1-Acid Glycoprotein and Alpha-1-Antichymotrypsin." Pediatric Infectious Disease Journal (2014).Read more>>
  • Yan Zhang. et al. Proteomic analysis of multiple organ dysfunction induced by rhabdomyolysis. J PROTEOMICS. 2024 Apr;298:105138Read more>>
VALIDATION IMAGES